Ifabotuzumab Antibody
Ifabotuzumab (KB-004) is a monoclonal antibody targeting EphA3, demonstrating efficacy in preclinical fibrosis models. It reduces CCR10+ cell populations and ameliorates pulmonary fibrosis in humanized NSG mice, supporting its research use in oncology and fibrotic disease investigations.
Product Specifications
Product Name Alternative
Anti-EphA3 MAb, KB004, KB-004
Target
Apoptosis, Ephrin Receptor
Conjugation
Unconjugated
Field of Research
Cell Biology, Signal Transduction
Concentration
5.33 mg/mL
Purity
>95% (May vary between batches)
Molecular Weight
145.4 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
FHJ26412 100 Tests
Anti-Human CD85j/LILRB1/ILT2 Antibody (SAA0402), PE
Sign In for Pricing
View Details 
